Home > Food & Beverages > Proteins > Animal-Based Proteins > Lactoferrin Market

Lactoferrin Market Analysis

  • Report ID: GMI5014
  • Published Date: Sep 2023
  • Report Format: PDF

Lactoferrin Market Analysis

The iron absorbing function segment of lactoferrin market is projected to record over 7.4% CAGR from 2023 to 2032. Iron deficiency remains a global health concern, and lactoferrin is being increasingly utilized to enhance iron absorption in dietary supplements and fortified food products. The ability of lactoferrin to bind with iron and transport it effectively within the body makes it an attractive choice for addressing iron-deficiency anemia and related conditions. This segment is poised to observe substantial growth as more consumers seek natural alternatives to traditional iron supplements.
 

The infant formula application segment is anticipated to witness significant growth through 2032. Lactoferrin is naturally present in human breast milk and plays a vital role in infant nutrition, aiding in the absorption of iron and supporting the immune system development of newborns. As a result, lactoferrin is being incorporated into infant formula products to mimic the benefits of breast milk, thereby boosting its demand. The increasing birth rate and the trend towards breastfeeding alternatives further fuel the growth of this segment, making it a significant contributor to the overall market.
 

Asia Pacific lactoferrin market is estimated to register gains at nearly 7.7% up to 2032. The increasing disposable income, growing awareness of health and wellness, and a booming pharmaceutical and nutraceutical industry in countries like China, Japan, and India have led to a surge in demand for lactoferrin-based products. Moreover, the region's robust dairy industry serves as a steady source of lactoferrin. This factor, along with the government initiatives to improve infant nutrition in countries with large populations, such as China and India, is making Asia Pacific a lucrative avenue for lactoferrin producers to explore and exploit in the coming years.

Authors: Kunal Ahuja, Sarita Bayas

Frequently Asked Questions (FAQ) :

The market size of lactoferrin is predicted to witness more than 7.2% CAGR from 2023 to 2032, due to its diverse range of health benefits and applications.

The infant formula application segment is anticipated to witness significant growth through 2032, as lactoferrin is being incorporated into infant formula products to mimic the benefits of breast milk.

Asia Pacific lactoferrin industry is expected to observe over 7.7% CAGR from 2023 to 2032, backed by the increasing disposable income, growing awareness of health and wellness, and a booming pharmaceutical and nutraceutical industry.

Westland Cooperative Dairy Co., Ltd., Pharming Group NV, APS BioGroup, Glanbia plc, Synlait Milk Ltd., MP Biomedicals, Warrnambool Cheese and Butter Company, Bega Cheese Limited, Metagenics, Inc., Ferrin-Tech LLC, ND Pharma & Biotech Ltd., and Fonterra Cooperative Group Ltd. among others.

Lactoferrin Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 17
  • Tables & Figures: 509
  • Countries covered: 20
  • Pages: 365
 Download Free Sample